We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+9.23%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$540M
AUM Growth
-$17.9M
(-3.2%)
Cap. Flow
-$41M
Cap. Flow
% of AUM
-7.6%
Top 10 Holdings %
Top 10 Hldgs %
26.96%
Holding
716
New
62
Increased
152
Reduced
248
Closed
35
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Malaysia ETF
EWM
|
+$10.3M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$9.74M |
| 3 |
IBM
IBM
|
+$8.96M |
| 4 |
iShares MSCI China ETF
MCHI
|
+$8.57M |
| 5 |
Linde
LIN
|
+$7.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$21.8M |
| 2 |
Stellantis
STLA
|
+$20.9M |
| 3 |
iShares MSCI Philippines ETF
EPHE
|
+$11.4M |
| 4 |
Ferrari
RACE
|
+$10.4M |
| 5 |
Deutsche Bank
DB
|
+$9.96M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.08% |
| 2 | Consumer Discretionary | 12.84% |
| 3 | Technology | 8.88% |
| 4 | Materials | 7.83% |
| 5 | Industrials | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Nektar Therapeutics
NKTR
$2.43B
| $331K | 0.06% |
940
-1,063
| -53% | -$308K |
|
202
Alcoa
AA
$11.6B
| $307K | 0.06% |
15,203
+1,072
| +8% | +$22.2K |
|
203
iShares MSCI Brazil ETF
EWZ
$9.04B
| $307K | 0.06% |
6,702
-9,067
| -57% | -$397K |
|
|
HUYA
204
Huya Inc
HUYA
$554M
| $306K | 0.06% |
14,795
-2,135
| -13% | -$45.1K |
|
|
URG
205
Ur-Energy
URG
$497M
| $301K | 0.06% |
529,000
-100,000
| -16% | -$58.9K |
|
206
Global X FinTech ETF
FINX
$170M
| $300K | 0.06% |
9,500
| – | – |
|
207
Molson Coors Class B
TAP
$7.74B
| $295K | 0.05% |
5,270
-1,141
| -18% | -$61.4K |
|
208
Tilray
TLRY
$488M
| $292K | 0.05% |
1,366
+16
| +1% | +$3.31K |
|
209
Applied Materials
AMAT
$405B
| $292K | 0.05% |
4,712
-967
| -17% | -$54.3K |
|
210
AngloGold Ashanti
AU
$40.4B
| $280K | 0.05% |
13,446
+992
| +8% | +$20K |
|
|
PPL
211
PPL Corp
PPL
$27.2B
| $279K | 0.05% |
7,789
-4,487
| -37% | -$150K |
|
212
NXP Semiconductors
NXPI
$67.4B
| $277K | 0.05% |
2,093
+459
| +28% | +$53.3K |
|
|
ACB
213
Aurora Cannabis
ACB
$168M
| $276K | 0.05% |
1,122
+896
| +396% | +$334K |
|
214
CALL
VanEck Gold Miners ETF
GDX
$22.9B
| $274K | 0.05% |
930
+430
| +86% | +$11.8K |
|
215
iShares Biotechnology ETF
IBB
$9.53B
| $271K | 0.05% |
2,230
| – | – |
|
216
Franco-Nevada
FNV
$41.2B
| $270K | 0.05% |
2,634
| – | – |
|
217
Consolidated Edison
ED
$41.5B
| $267K | 0.05% |
3,004
-1,346
| -31% | -$121K |
|
218
Dominion Energy
D
$62.5B
| $266K | 0.05% |
3,209
+624
| +24% | +$51K |
|
219
Sarepta Therapeutics
SRPT
$1.7B
| $263K | 0.05% |
2,023
| – | – |
|
|
220
VanEck Gold Miners ETF
GDX
$22.9B
| $263K | 0.05% |
9,122
-163,805
| -95% | -$4.48M |
|
221
Expedia Group
EXPE
$32.6B
| $258K | 0.05% |
2,331
+1,419
| +156% | +$167K |
|
|
222
CALL
iShares MSCI Emerging Markets ETF
EEM
$28.5B
| $248K | 0.05% |
1,500
-1
| -0.1% | -$43 |
|
|
BZUN
223
Baozun
BZUN
$160M
| $234K | 0.04% |
6,514
-2,752
| -30% | -$109K |
|
224
Sea Limited
SE
$64.4B
| $234K | 0.04% |
5,782
-2,393
| -29% | -$80.6K |
|
225
Home Depot
HD
$338B
| $233K | 0.04% |
1,038
+265
| +34% | +$60K |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q4 2019 Portfolio in Review
As of Q4 2019, Exane Derivatives held 716 positions worth $540M, down 3.2% from $558M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Exane Derivatives withdrew a net $41M in Q4 2019, closing 35 positions and reducing 248 holdings. Its most notable exit was iShares MSCI Indonesia ETF, an estimated $6.83M position sold in full.
By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, Exane Derivatives opened a new position in IBM worth $9M.
- Exane Derivatives's largest Q4 2019 buy was IBM: 68,905 shares worth $9M.
- Exane Derivatives added most to iShares MSCI Malaysia ETF in Q4 2019, an estimated $10.3M increase.
- Exane Derivatives's biggest Q4 2019 reduction was UBS Group, cutting an estimated $21.8M.
- Exane Derivatives fully exited iShares MSCI Indonesia ETF in Q4 2019, selling an estimated $6.83M.
- Exane Derivatives's ten largest holdings make up 27% of its $540M portfolio in Q4 2019.
- Exane Derivatives opened 62 new positions and closed 35 in Q4 2019.
- Exane Derivatives's portfolio value fell 3.2% quarter-over-quarter to $540M.
Based on Exane Derivatives's 13F filing for Q4 2019, filed 22 Jan 2020.